Essential Pharmaceuticals, LLC

essentialpharma.com

Essential Pharmaceuticals, LLC was established in 2006 with the distribution rights to Custodiol® HTK organ preservation solution.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMACY MARKET

DIRECTRX ANNOUNCES REBRANDING SPECIALTY PHARMACY SERVICES

DirectRx Pharmacy | February 15, 2023

news image

On February 14, 2023, DirectRx, a leading national specialty pharmacy committed to serving individual patients with chronic and complex health needs, announced the launch of a new website and a suite of team member training programs. The new website emphasizes the company's dedication to working with patients and prescribers to provide the best possible care. The training programs are designed to assist team members in developing professionally. The DirectRx websi...

Read More

Pharmacy Market

ALPHA COGNITION ANNOUNCES POSITIVE NEUROPROTECTION DATA FROM PRE-CLINICAL STUDY OF ALPHA-1062 FOR TRAUMATIC BRAIN INJURY

Alpha Cognition Inc. | February 23, 2022

news image

Alpha Cognition Inc. a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce histology data from their intranasal ALPHA-1062 Traumatic Brain Injury (TBI) program. ALPHA-1062 treatment was neuroprotective, preserving hippocampal structure, reducing cell loss and promoting neurogenesis compared to no treatment. Functional recovery data released in December demonstra...

Read More

Pharmacy Market

NEXUS PHARMACEUTICALS RECEIVES FDA APPROVAL FOR STERILE WATER FOR INJECTION, USP

Businesswire | July 26, 2023

news image

Nexus Pharmaceuticals announced it has received U.S. Food and Drug Administration (FDA) approval for Sterile Water for Injection, USP in 10mL and 20mL Single-Dose Vials. According to the FDA and the FD&C Act, the product is considered bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Sterile Water for Injection USP, of Hospira, Inc. Furthermore, the FDA has granted CGT (competitive generic therapy) designation for the 20mL presentation of steri...

Read More

FOLLOWING LAB TEST, EAGLE PHARMA LOOKS TO TEST MH DRUG RYANODEX AGAINST COVID-19

BioSpace | April 16, 2020

news image

In a controlled laboratory test, Eagle Pharmaceuticals’ malignant hyperthermia treatment Ryanodex (dantrolene sodium) inhibited the growth of SARS-CoV-2, the virus causing the COVID-19 pandemic. Now the company hopes to launch a clinical trial testing the efficacy of the drug in patients. In the in vitro tests, Ryanodex demonstrated antiviral activity and a lack of cytotoxicity. Two days after dosing, the in vitro results showed an absence of cytopathic effects in the infected cells. This ...

Read More
news image

Business Insights, PHARMACY MARKET

DIRECTRX ANNOUNCES REBRANDING SPECIALTY PHARMACY SERVICES

DirectRx Pharmacy | February 15, 2023

On February 14, 2023, DirectRx, a leading national specialty pharmacy committed to serving individual patients with chronic and complex health needs, announced the launch of a new website and a suite of team member training programs. The new website emphasizes the company's dedication to working with patients and prescribers to provide the best possible care. The training programs are designed to assist team members in developing professionally. The DirectRx websi...

Read More
news image

Pharmacy Market

ALPHA COGNITION ANNOUNCES POSITIVE NEUROPROTECTION DATA FROM PRE-CLINICAL STUDY OF ALPHA-1062 FOR TRAUMATIC BRAIN INJURY

Alpha Cognition Inc. | February 23, 2022

Alpha Cognition Inc. a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce histology data from their intranasal ALPHA-1062 Traumatic Brain Injury (TBI) program. ALPHA-1062 treatment was neuroprotective, preserving hippocampal structure, reducing cell loss and promoting neurogenesis compared to no treatment. Functional recovery data released in December demonstra...

Read More
news image

Pharmacy Market

NEXUS PHARMACEUTICALS RECEIVES FDA APPROVAL FOR STERILE WATER FOR INJECTION, USP

Businesswire | July 26, 2023

Nexus Pharmaceuticals announced it has received U.S. Food and Drug Administration (FDA) approval for Sterile Water for Injection, USP in 10mL and 20mL Single-Dose Vials. According to the FDA and the FD&C Act, the product is considered bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Sterile Water for Injection USP, of Hospira, Inc. Furthermore, the FDA has granted CGT (competitive generic therapy) designation for the 20mL presentation of steri...

Read More
news image

FOLLOWING LAB TEST, EAGLE PHARMA LOOKS TO TEST MH DRUG RYANODEX AGAINST COVID-19

BioSpace | April 16, 2020

In a controlled laboratory test, Eagle Pharmaceuticals’ malignant hyperthermia treatment Ryanodex (dantrolene sodium) inhibited the growth of SARS-CoV-2, the virus causing the COVID-19 pandemic. Now the company hopes to launch a clinical trial testing the efficacy of the drug in patients. In the in vitro tests, Ryanodex demonstrated antiviral activity and a lack of cytotoxicity. Two days after dosing, the in vitro results showed an absence of cytopathic effects in the infected cells. This ...

Read More

Resources

resource image

Business Insights, PHARMACY MARKET

ESSENTIAL SOFT TECHNOLOGY

Video

resource image

Business Insights, PHARMACY MARKET

ESSENTIAL SOFT TECHNOLOGY

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us